Tesamorelin + Ipamorelin Blend Research Performance Metrics

For a blended research compound, every metric a buyer can legitimately evaluate is analytical. That means purity by HPLC for each peptide present, identity confirmation by mass spectrometry, net peptide content, the verified ratio of the two sequences in the vial, and contamination screening — all tied to a specific lot number on a certificate of analysis you can read before money moves. Research-use-only compounds carry no performance data in people, and a supplier who offers you some is handing you a liability rather than a spec sheet. The useful question for a wholesale buyer is narrower: can this lot be proven to be what the label says it is?

The numbers that actually belong on a purchase decision

When a distributor says a blend "performs well," ask which assay produced that sentence. The metrics below are the ones a laboratory can generate, a document can record, and a buyer can check against the vial in hand.

Chromatographic purity. Reversed-phase HPLC separates the target peptide from truncated sequences, deletion products, oxidation byproducts and synthesis residue. Purity is reported as the percentage of total peak area attributable to the target peak. A 99%+ purity standard is the benchmark serious research suppliers hold; anything materially below it means more unknown material in the vial than most study designs tolerate.

Identity by mass spectrometry. Purity tells you the sample is clean. Identity tells you it is the right molecule. MS confirms the observed molecular weight against the theoretical weight of the sequence. Without it, a high-purity result only proves that something was consistently manufactured.

Net peptide content. Lyophilized peptide powder is not pure peptide by mass. It carries counter-ions from synthesis — trifluoroacetate or acetate — plus residual water. A vial labeled 10mg may contain meaningfully less actual peptide if content was never quantified. Net peptide content is the metric that reconciles label weight with real material, and it is one of the most frequently omitted lines on a thin COA.

Water content. Measured by Karl Fischer titration, residual moisture is a leading predictor of how a lyophilized powder behaves in storage. High water content correlates with faster degradation and with cake collapse in the vial.

Contamination screening. Bioburden, endotoxin, heavy metals and residual solvents are the categories that separate a manufacturing process with controls from one without. These do not appear on a purity report; they require separate panels.

Physical and reconstitution behavior. A well-formed lyophilized cake that goes into solution cleanly is a crude but real quality signal. Cloudiness, visible particulate or incomplete dissolution is worth documenting and escalating with the supplier before the rest of the order moves into your inventory.

Why a two-peptide vial raises the analytical bar

A blend is not simply two compounds in one container from a verification standpoint. It is a single product with two active sequences, which changes what a certificate has to prove and how easily it can hide a gap.

Co-elution is the failure mode worth understanding. If two peptides elute at or near the same retention time under the method used, a chromatogram can look clean while concealing how much of each is actually present. Resolving that requires a method developed for the pair, not a generic gradient borrowed from a single-compound run. Ratio drift is the second. Even a correctly formulated blend can shift over time if the two sequences have different stability profiles, which means a ratio verified at manufacture is not automatically the ratio in the vial months later.

None of this makes blends illegitimate. It makes them harder to qualify, and it means a blend COA has to be more detailed than a single-compound COA, not less. In practice, the opposite is common.

What the science says about these two sequences — and what it does not

Tesamorelin is a synthetic analog of growth hormone-releasing hormone. Research literature describes it as acting at pituitary GHRH receptors, within the endogenous signaling axis rather than as exogenous growth hormone. Ipamorelin is a pentapeptide studied as a selective agonist at the growth hormone secretagogue receptor — the ghrelin receptor — and much of the published interest in it concerns its receptor selectivity relative to earlier secretagogue compounds.

The reason the two appear together in study designs is mechanistic rather than promotional: research indicates they engage distinct receptor pathways, and investigators studying convergent signaling have reason to examine them in parallel. That is the honest extent of it. Studies suggest avenues of inquiry; they do not establish outcomes, and nothing about the pairing supports a claim of benefit in people. Any supplier marketing that frames a blend in terms of results, timelines or body composition is describing a human therapeutic, and these compounds are not that. They are research chemicals, sold for laboratory investigation only, and the framing you accept from a supplier tends to become the framing that ends up on your own materials.

There is also a practical argument for sourcing the two sequences as separate, individually certified vials rather than as a pre-blended product: every verification problem in the table above disappears. Each compound gets its own purity figure, its own identity confirmation, its own content value and its own stability profile, and the researcher controls the study design rather than inheriting a fixed formulation decision from a manufacturer.

Reading a certificate of analysis like a buyer

Most wholesale disappointments trace back to a document nobody examined closely. A few habits catch the majority of problems.

Match the lot. The lot number on the COA must match the lot printed on the vial you received. A COA for a different batch is a marketing asset, not a quality record. Check the test date, too — a certificate should correspond to the batch in front of you, not to a representative sample from an earlier run.

Look for the chromatogram, not just the number. A purity percentage typed into a template costs nothing to produce. The chromatogram shows peak shape, baseline and retention time, and it is where a trained eye sees whether the number is supported.

Confirm the methods and the testing party. A credible certificate names the analytical methods used and identifies who ran them. "Third-party tested" as a bare phrase, with no laboratory named and no document attached, is a claim about a claim.

Notice how hard the document is to get. Industry practice varies sharply here, and it is one of the more reliable signals available to a buyer. Some suppliers publish batch results openly. Others treat COAs as a paid add-on, release them only after an order is placed, or supply a single undated document reused across every lot. The same pattern often shows up in pricing — tiers that are never published, quoted differently to different buyers, and adjusted after you have committed. You do not need inside information about any particular company to apply the rule: if the quality documentation and the pricing both require a negotiation to see, you are not evaluating a supplier, you are being evaluated.

The questions that belong with your attorney, not your supplier

How research-use-only compounds may be purchased, stored, labeled, resold or incorporated into a business is not something a vendor can settle for you, and this section is informational rather than legal advice. The useful move is to arrive at counsel with the right questions rather than expecting a supplier to answer them.

Ask your attorney how research-use-only designation interacts with your specific business model and entity type. Ask what your state's licensing framework requires of a business that stocks or resells research materials, and whether your professional board — if you hold a license — has a position that applies. Ask what labeling and recordkeeping your jurisdiction expects, and what documentation you should retain per lot. Rules differ meaningfully between states and change over time, so verify current requirements with your state board and your own counsel rather than relying on general guidance, including this article.

If your work involves animal research, oversight is institutional rather than commercial: talk to your veterinarian and your institutional animal care and use committee about protocol requirements before material is ordered, because that review governs what may be acquired and how it must be documented.

What Real Peptides does differently

Real Peptides builds its Wholesale Partner Program around documentation a buyer can check independently. Compounds are held to a 99%+ HPLC purity standard and run through seven-panel batch testing, and the resulting certificates of analysis are publicly verifiable — the reader can pull the lab results for a batch and read them without asking a sales representative for permission, without a paywall, and without placing an order first. That is the point of publishing them: a purity figure a buyer cannot independently confirm is a marketing number.

The catalog carries Tesamorelin 10mg and Ipamorelin 10mg as separate single-compound vials, each with its own batch documentation — which, for a researcher evaluating these two sequences, removes the co-elution and ratio-verification problems that a pre-blended vial introduces. Orders ship from US fulfillment in 5–7 days, and wholesale pricing is reached through a three-step application rather than an open-ended quoting process. All compounds are supplied for research use only and are not FDA-approved drugs.

Where a qualified buyer goes next

If you are stocking research compounds for a med spa, clinic, telehealth company or reseller catalog and you want supply you can document rather than vouch for, the Wholesale Partner Program application at realpeptides.co is the path — three steps, with pricing tiers and batch documentation available to review as part of the process rather than after it.

Buyers researching adjacent compounds can review the Growth Factor & Tissue Signaling Research and Performance & Recovery Research collections, compare the most-requested catalog items under Popular Peptides, or look at how the same testing standard applies to widely studied compounds such as BPC-157 10mg and CJC-1295 No DAC 10mg.

Research Use and Legal Notice

This page is general information and is not legal advice. Consult your attorney about the rules that apply to your business.